Search results
Asthma Triggers In Homes Can Send Kids to the ER—This Organization Is Working to Change That
Health.com· 4 days agoFor parents of children with asthma, witnessing an attack of severe symptoms can be a terrifying...
GSK’s Potential Blockbuster Asthma Drug Shows Promise in Latest Trial
The Wall Street Journal· 4 days agoDepemokimab could be the first approved drug to allow a long-term dosing interval, requiring only...
GSK’s asthma drug shows promise in reducing severe attacks
WSAU Wausau· 4 days ago(Reuters) - GSK's asthma drug met its primary goal of reducing asthma attacks over a 52-week period...
Eosinophilic Asthma
Health via Yahoo News· 6 days agoConsider the following: Being 35-50 years old Having a personal or family history of asthma or other allergic conditions Smoking tobacco Diagnosis If you...
Discrimination and negligence at Seattle Children’s hospital led to teen’s death, family alleges in...
CNN via AOL· 3 hours agoA 16-year-old in Bothell, Washington, suffered from a severe allergic reaction to medication for...
GSK's Experimental Asthma Drug Reduces Severe Attacks, Phase 3 Trial Data Shows
Benzinga via Yahoo Finance· 4 days agoTuesday, GSK plc (NYSE:GSK) released headline results from the phase III clinical trials SWIFT-1 and...
Are your seasonal allergies worse this year? Here's why—plus tips for symptom relief
CNBC· 7 days agoMore severe symptoms of seasonal allergies this spring are likely due to a warmer winter and an...
GSK Studies on Depemokimab for Severe Asthma Meet Primary Goals
Zacks via Yahoo Finance· 3 days agoGSK’s GSK two-phase III studies, which evaluated depemokimab for treating severe asthma...
Northeast Ohio Black Health Coalition promotes air quality and asthma awareness
WFMJ Youngstown· 6 hours agoThose who suffer from asthma attacks know an attack can be severe, or even fatal. But not everyone...
GSK boasts win for depemokimab in asthma trials
Clinical Trials Arena via Yahoo Finance· 4 days agoThe two randomised, multi-centre, placebo-controlled trials investigated depemokimab in adults and adolescents with severe asthma with type 2...